Get the Stockscreener App
0.4287
0.28%
-0.0012
After Hours:
.4287
ASLAN Pharmaceuticals Ltd ADR Stock (ASLN) Forecast
The ASLAN Pharmaceuticals Ltd ADR (ASLN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $1.5799, representing a +268.54% increase from the current price of $0.4287. The highest analyst price target is $1.4458, and the lowest is $1.7141.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month ASLN Price Target
Average 13.27
(+2,996% Upside)
Is ASLAN Pharmaceuticals Ltd ADR (ASLN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 44.47 | Neutral |
| STOCH(9,6) | 28.72 | Neutral |
| STOCHRSI(14) | 35.05 | Neutral |
| MACD(12,26) | -0.0128 | Buy |
| ADX(14) | 14.81 | Neutral |
| William %R | -76.18 | Neutral |
| CCI(14) | -38.78 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
0.4527
Sell
|
0.441
Sell
|
| MA20 |
0.4343
Sell
|
0.447
Sell
|
| MA50 |
0.4929
Sell
|
0.4923
Sell
|
| MA100 |
0.563
Sell
|
0.6205
Sell
|
| MA200 |
0.9194
Sell
|
1.133
Sell
|
Buy: 0
Sell: 10
Neutral: 0
Summary: Sell
According to our latest analysis, ASLN could be considered a Strong Sell, with 17 technical analysis indicators signaling 1 Buy signals, 10 signaling Sell signals and 6 Neutral signals. This might not be a good time to consider opening new positions on ASLN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 44.47 indicates that ASLN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 28.72 indicates that ASLN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 35.05 indicates that ASLN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 14.81 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -38.78 indicates that ASLN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term ASLN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about ASLAN Pharmaceuticals Ltd ADR financial reports and earnings history, ASLAN Pharmaceuticals Ltd ADR (ASLN) stock could reach $18.28 by 2030, $9.8591 by 2040 and $36.93 by 2050. See the projected annual prices until 2050 of the ASLAN Pharmaceuticals Ltd ADR stock below:
- ASLAN Pharmaceuticals Ltd ADR (ASLN) is expected to reach an average price of $3.4623 in 2035, with a high prediction of $3.5823 and a low estimate of $3.3931. This indicates an $707.64% rise from the last recorded price of $0.4287.
- ASLAN Pharmaceuticals Ltd ADR (ASLN) stock is projected to chart a bullish course in 2040, with an average price target of $8.3203, representing an $1,841% surge from its current level. The forecast ranges from a conservative $8.5217 to a sky-high $9.8591.
- Our analysts predict ASLAN Pharmaceuticals Ltd ADR (ASLN) to jump 4,992% by 2045, soaring from $21.59 to an average price of $21.83, potentially reaching $21.57. While $21.59 is the low estimate, the potential upside is significant.
- ASLAN Pharmaceuticals Ltd ADR (ASLN) stock is expected to climb by 2050, reaching an average of $36.57, a $8,430% jump from its current level. However, a wide range of estimates exists, with high and low targets of $36.93 and $36.79, respectively, highlighting the market's uncertainty.
ASLAN Pharmaceuticals Ltd ADR Stock (ASLN) Year by Year Forecast
ASLAN Pharmaceuticals Ltd ADR Stock (ASLN) Price Forecast for 2024
Our forecast for ASLN stock price in 2024 now indicates an average price target of $12.52 with a high forecast of $24.83 and a low forecast of $0.2071. The average prediction reflects an increase of +2,820% from the last recorded price of $0.4287.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| July, 2024 | $1.3247 | $1.7141 | $1.4458 | +208.99% |
| August, 2024 | $8.2852 | $2.0148 | $3.5852 | +1,833% |
| September, 2024 | $7.8458 | $7.9208 | $7.7254 | +1,730% |
| October, 2024 | $8.5465 | $8.314 | $8.3564 | +1,894% |
| November, 2024 | $5.9071 | $8.2221 | $7.9268 | +1,278% |
| December, 2024 | $4.0677 | $5.5177 | $24.83 | +848.85% |
ASLAN Pharmaceuticals Ltd ADR Stock (ASLN) Price Forecast for 2025
ASLAN Pharmaceuticals Ltd ADR Stock (ASLN) is expected to reach an average price of $6.7478 in 2025, with a high prediction of $9.7805 and a low estimate of $3.7152. This indicates an +1,474% rise from the last recorded price of $0.4287.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $4.8684 | $5.3882 | $4.7283 | +1,036% |
| February, 2025 | $5.721 | $4.0987 | $3.879 | +1,235% |
| March, 2025 | $6.2396 | $5.0093 | $4.8396 | +1,355% |
| April, 2025 | $9.9403 | $6.2563 | $9.4903 | +2,219% |
| May, 2025 | $6.5014 | $7.2509 | $9.7805 | +1,417% |
| June, 2025 | $6.1615 | $6.7312 | $6.2812 | +1,337% |
| July, 2025 | $4.6122 | $5.4122 | $5.1918 | +975.87% |
| August, 2025 | $4.6228 | $4.3357 | $4.0925 | +978.34% |
| September, 2025 | $5.5334 | $5.3051 | $5.3334 | +1,191% |
| October, 2025 | $6.2881 | $5.7747 | $5.7841 | +1,367% |
| November, 2025 | $3.6947 | $4.2947 | $5.6243 | +761.85% |
| December, 2025 | $4.596 | $3.7152 | $3.6455 | +972.07% |
ASLAN Pharmaceuticals Ltd ADR Stock (ASLN) Price Forecast for 2026
The predicted value for ASLAN Pharmaceuticals Ltd ADR (ASLN) in 2026 is set at an average of $11.39. Estimates vary from a peak of $21.99 to a trough of $0.798, indicating an +2,558% surge from the present price of $0.4287.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $3.256 | $4.106 | $4.5856 | +659.52% |
| February, 2026 | $1.9166 | $3.0166 | $3.1712 | +347.08% |
| March, 2026 | $2.5772 | $2.7418 | $2.4464 | +501.17% |
| April, 2026 | $7.3221 | $0.8476 | $9.5131 | +1,608% |
| May, 2026 | $8.9615 | $3.1918 | $21.99 | +1,990% |
| June, 2026 | $5.3509 | $4.5312 | $9.2208 | +1,148% |
| July, 2026 | $1.7502 | $1.4002 | $6.1805 | +308.25% |
| August, 2026 | $4.9396 | $1.758 | $5.5286 | +1,052% |
| September, 2026 | $6.4889 | $4.4889 | $8.5494 | +1,414% |
| October, 2026 | $4.4783 | $2.4586 | $6.3487 | +944.62% |
| November, 2026 | $3.2677 | $0.798 | $5.1881 | +662.23% |
| December, 2026 | $0.833 | $1.983 | $6.9566 | +94.32% |
ASLAN Pharmaceuticals Ltd ADR Stock (ASLN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for ASLAN Pharmaceuticals Ltd ADR (ASLN) is $3.206, with a high forecast of $5.2889 and a low forecast of $1.1232. This indicates an +647.85% increase from the last price of $0.4287.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $2.1436 | $1.1232 | $1.2936 | +400.03% |
| February, 2027 | $1.2542 | $1.1239 | $0.7838 | +192.56% |
| March, 2027 | $2.8549 | $2.1444 | $2.2549 | +565.95% |
| April, 2027 | $3.3655 | $3.0951 | $3.0655 | +685.05% |
| May, 2027 | $3.4261 | $3.7761 | $3.6945 | +699.19% |
| June, 2027 | $4.4268 | $3.6158 | $3.7867 | +932.62% |
| July, 2027 | $3.4889 | $3.7374 | $4.017 | +713.84% |
| August, 2027 | $4.348 | $3.5776 | $3.798 | +914.23% |
| September, 2027 | $5.4832 | $4.3881 | $5.1597 | +1,179% |
| October, 2027 | $5.2743 | $5.3533 | $5.2889 | +1,130% |
| November, 2027 | $4.3684 | $4.4699 | $4.3995 | +918.99% |
| December, 2027 | $2.4301 | $4.0701 | $4.3908 | +466.86% |
ASLAN Pharmaceuticals Ltd ADR Stock (ASLN) Price Forecast for 2028
In 2028, ASLAN Pharmaceuticals Ltd ADR (ASLN) is projected to reach an average price of $1.8977, with a high projection of $3.7925 and a low estimate of $0.00295. This indicates an +342.67% rise from the last price of $0.4287.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.0812 | $2.4509 | $2.8322 | +618.74% |
| February, 2028 | $3.1983 | $2.6565 | $2.9913 | +646.05% |
| March, 2028 | $3.8725 | $3.4819 | $3.7925 | +803.32% |
| April, 2028 | $2.6531 | $3.2571 | $3.6827 | +518.87% |
| May, 2028 | $3.4518 | $2.8784 | $2.9538 | +705.19% |
| June, 2028 | $1.8014 | $2.0644 | $3.2445 | +320.21% |
| July, 2028 | $0.9255 | $1.2575 | $1.2947 | +115.89% |
| August, 2028 | $1.7252 | $0.9652 | $0.8361 | +302.44% |
| September, 2028 | $1.7163 | $1.7363 | $1.3072 | +300.36% |
| October, 2028 | $0.1131 | $0.2082 | $0.6665 | -73.62% |
| November, 2028 | $0.4024 | $0.00295 | $0.6728 | -6.14% |
| December, 2028 | $0.0918 | $0.0189 | $0.6119 | -78.59% |
ASLAN Pharmaceuticals Ltd ADR Stock (ASLN) Price Forecast for 2029
The 2029 price forecast for ASLAN Pharmaceuticals Ltd ADR Stock (ASLN) is $8.1007 on average, with a high prediction of $16.14 and a low estimate of $0.0657. This represents an +1,790% increase from the previous price of $0.4287.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $0.8989 | $0.6887 | $0.834 | +109.69% |
| February, 2029 | $1.0095 | $1.0094 | $0.8894 | +135.49% |
| March, 2029 | $0.7901 | $0.7899 | $0.7748 | +84.31% |
| April, 2029 | $1.2607 | $0.9054 | $0.9827 | +194.08% |
| May, 2029 | $1.1614 | $1.2314 | $1.2211 | +170.92% |
| June, 2029 | $1.372 | $1.2116 | $1.291 | +220.04% |
| July, 2029 | $1.2405 | $1.3706 | $1.3362 | +189.36% |
| August, 2029 | $0.7808 | $0.882 | $1.1367 | +82.14% |
| September, 2029 | $0.8163 | $0.7838 | $0.7539 | +90.42% |
| October, 2029 | $0.2716 | $0.2846 | $1.1055 | -36.64% |
| November, 2029 | $0.1732 | $0.2252 | $0.1849 | -59.59% |
| December, 2029 | $17.59 | $0.0657 | $16.14 | +4,002% |
ASLAN Pharmaceuticals Ltd ADR Stock (ASLN) Price Forecast for 2030
ASLAN Pharmaceuticals Ltd ADR Stock (ASLN) is expected to reach an average price of $21.71 in 2030, with a high forecast of $25.04 and a low forecast of $18.37. This signifies an +4,963% surge from the last price of $0.4287.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $18.14 | $18.37 | $18.28 | +4,131% |
| February, 2030 | $18.16 | $19.28 | $17.33 | +4,136% |
| March, 2030 | $18.46 | $19.28 | $18.07 | +4,205% |
| April, 2030 | $25.78 | $21.29 | $24.75 | +5,913% |
| May, 2030 | $24.85 | $24.77 | $24.55 | +5,697% |
| June, 2030 | $24.97 | $25.24 | $24.96 | +5,725% |
| July, 2030 | $24.57 | $24.53 | $25.04 | +5,632% |
| August, 2030 | $21.00 | $21.59 | $18.92 | +4,798% |
| September, 2030 | $19.72 | $21.28 | $20.56 | +4,499% |
| October, 2030 | $20.22 | $19.75 | $19.59 | +4,616% |
| November, 2030 | $24.34 | $20.60 | $20.13 | +5,578% |
| December, 2030 | $25.19 | $25.13 | $24.71 | +5,775% |
0.79%
3.50%
Cap:
|
Volume (24h):